269 related articles for article (PubMed ID: 23814180)
1. The role of human equilibrative nucleoside transporter 1 on the cellular transport of the DNA methyltransferase inhibitors 5-azacytidine and CP-4200 in human leukemia cells.
Hummel-Eisenbeiss J; Hascher A; Hals PA; Sandvold ML; Müller-Tidow C; Lyko F; Rius M
Mol Pharmacol; 2013 Sep; 84(3):438-50. PubMed ID: 23814180
[TBL] [Abstract][Full Text] [Related]
2. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
SenGupta DJ; Unadkat JD
Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
[TBL] [Abstract][Full Text] [Related]
3. Role of human nucleoside transporters in the uptake and cytotoxicity of azacitidine and decitabine.
Damaraju VL; Mowles D; Yao S; Ng A; Young JD; Cass CE; Tong Z
Nucleosides Nucleotides Nucleic Acids; 2012; 31(3):236-55. PubMed ID: 22356238
[TBL] [Abstract][Full Text] [Related]
4. Human equilibrative nucleoside transporter-1 (hENT1) is required for the transcriptomic response of the nucleoside-derived drug 5'-DFUR in breast cancer MCF7 cells.
Molina-Arcas M; Moreno-Bueno G; Cano-Soldado P; Hernández-Vargas H; Casado FJ; Palacios J; Pastor-Anglada M
Biochem Pharmacol; 2006 Dec; 72(12):1646-56. PubMed ID: 16965766
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the human equilibrative nucleoside transporter1 (hENT1) activity by IL-4 and PMA in B cells from chronic lymphocytic leukemia.
Fernández Calotti P; Galmarini CM; Cañones C; Gamberale R; Saénz D; Avalos JS; Chianelli M; Rosenstein R; Giordano M
Biochem Pharmacol; 2008 Feb; 75(4):857-65. PubMed ID: 18078872
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer.
Santini D; Vincenzi B; Fratto ME; Perrone G; Lai R; Catalano V; Cass C; Ruffini PA; Spoto C; Muretto P; Rizzo S; Muda AO; Mackey JR; Russo A; Tonini G; Graziano F
J Cell Physiol; 2010 May; 223(2):384-8. PubMed ID: 20082300
[TBL] [Abstract][Full Text] [Related]
7. Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1.
Lepist EI; Damaraju VL; Zhang J; Gati WP; Yao SY; Smith KM; Karpinski E; Young JD; Leung KH; Cass CE
Drug Metab Dispos; 2013 Apr; 41(4):916-22. PubMed ID: 23388705
[TBL] [Abstract][Full Text] [Related]
8. High expression of the human equilibrative nucleoside transporter 1 gene predicts a good response to decitabine in patients with myelodysplastic syndrome.
Wu L; Shi W; Li X; Chang C; Xu F; He Q; Wu D; Su J; Zhou L; Song L; Xiao C; Zhang Z
J Transl Med; 2016 Mar; 14():66. PubMed ID: 26944860
[TBL] [Abstract][Full Text] [Related]
9. Investigating the role of nucleoside transporters in the resistance of colorectal cancer to 5-fluorouracil therapy.
Phua LC; Mal M; Koh PK; Cheah PY; Chan EC; Ho HK
Cancer Chemother Pharmacol; 2013 Mar; 71(3):817-23. PubMed ID: 23271323
[TBL] [Abstract][Full Text] [Related]
10. Equilibrative nucleoside transporter 2 is expressed in human umbilical vein endothelium, but is not involved in the inhibition of adenosine transport induced by hyperglycaemia.
Aguayo C; Casado J; González M; Pearson JD; Martín RS; Casanello P; Pastor-Anglada M; Sobrevia L
Placenta; 2005; 26(8-9):641-53. PubMed ID: 16085043
[TBL] [Abstract][Full Text] [Related]
11. Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells.
Cai J; Damaraju VL; Groulx N; Mowles D; Peng Y; Robins MJ; Cass CE; Gros P
Cancer Res; 2008 Apr; 68(7):2349-57. PubMed ID: 18381442
[TBL] [Abstract][Full Text] [Related]
12. Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia.
Lainey E; Wolfromm A; Marie N; Enot D; Scoazec M; Bouteloup C; Leroy C; Micol JB; De Botton S; Galluzzi L; Fenaux P; Kroemer G
Oncogene; 2013 Sep; 32(37):4331-42. PubMed ID: 23085751
[TBL] [Abstract][Full Text] [Related]
13. Cellular Uptake of Decitabine by Equilibrative Nucleoside Transporters in HCT116 Cells.
Ueda K; Hosokawa M; Iwakawa S
Biol Pharm Bull; 2015; 38(8):1113-9. PubMed ID: 26235575
[TBL] [Abstract][Full Text] [Related]
14. FLT3 is implicated in cytarabine transport by human equilibrative nucleoside transporter 1 in pediatric acute leukemia.
Català A; Pastor-Anglada M; Caviedes-Cárdenas L; Malatesta R; Rives S; Vega-García N; Camós M; Fernández-Calotti P
Oncotarget; 2016 Aug; 7(31):49786-49799. PubMed ID: 27391351
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the concentrative nucleoside transporter 3 and equilibrative nucleoside transporter 2 in the resistance of T-lymphoblastic cell lines to thiopurines.
Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
Biochem Biophys Res Commun; 2006 Apr; 343(1):208-15. PubMed ID: 16530731
[TBL] [Abstract][Full Text] [Related]
16. Insulin restores glucose inhibition of adenosine transport by increasing the expression and activity of the equilibrative nucleoside transporter 2 in human umbilical vein endothelium.
Muñoz G; San Martín R; Farías M; Cea L; Vecchiola A; Casanello P; Sobrevia L
J Cell Physiol; 2006 Dec; 209(3):826-35. PubMed ID: 16924660
[TBL] [Abstract][Full Text] [Related]
17. 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy.
Christman JK
Oncogene; 2002 Aug; 21(35):5483-95. PubMed ID: 12154409
[TBL] [Abstract][Full Text] [Related]
18. Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.
Atanackovic D; Luetkens T; Kloth B; Fuchs G; Cao Y; Hildebrandt Y; Meyer S; Bartels K; Reinhard H; Lajmi N; Hegewisch-Becker S; Schilling G; Platzbecker U; Kobbe G; Schroeder T; Bokemeyer C; Kröger N
Am J Hematol; 2011 Nov; 86(11):918-22. PubMed ID: 21898529
[TBL] [Abstract][Full Text] [Related]
19. Cellular localization and functional characterization of the equilibrative nucleoside transporters of antitumor nucleosides.
Endo Y; Obata T; Murata D; Ito M; Sakamoto K; Fukushima M; Yamasaki Y; Yamada Y; Natsume N; Sasaki T
Cancer Sci; 2007 Oct; 98(10):1633-7. PubMed ID: 17711502
[TBL] [Abstract][Full Text] [Related]
20. 5-azacytidine enhances efficacy of multiple chemotherapy drugs in AML and lung cancer with modulation of CpG methylation.
Füller M; Klein M; Schmidt E; Rohde C; Göllner S; Schulze I; Qianli J; Berdel WE; Edemir B; Müller-Tidow C; Tschanter P
Int J Oncol; 2015 Mar; 46(3):1192-204. PubMed ID: 25501798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
